Skip to main content
NCBI home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1977 May;11(5):773–779. doi: 10.1128/aac.11.5.773

Permeability Barrier to Rifampin in Mycobacteria

J Hui 1, N Gordon 1, R Kajioka 1
PMCID: PMC352073  PMID: 879732

Abstract

A strain of Mycobacterium intracellulare that exhibited natural resistance to rifampin was isolated. The ribonucleic acid polymerase was found to be susceptible to rifampin. Studies with Tween 80 suggested that a permeability barrier against rifampin was present in the intact organism. A type strain of Mycobacterium smegmatis, ATCC 607, considered resistant to rifampin also demonstrated a permeability barrier. The possibility that rifampin resistance in naturally occurring strains of mycobacteria and variable levels of resistance in strains of certain species of this organism are due to permeability barriers is discussed.

Full text

PDF
773

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. AUBERT E. Cold stain for acid-fast bacteria. Can J Public Health. 1950 Jan;41(1):31–31. [PubMed] [Google Scholar]
  2. Burgess R. R. A new method for the large scale purification of Escherichia coli deoxyribonucleic acid-dependent ribonucleic acid polymerase. J Biol Chem. 1969 Nov 25;244(22):6160–6167. [PubMed] [Google Scholar]
  3. DUBOS R. J. The effect of organic acids on mammalian tubercle bacilli. J Exp Med. 1950 Oct 1;92(4):319–332. doi: 10.1084/jem.92.4.319. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Ghysen A., Pironio M. Relationship between the N function of bacteriophage lambda and host RNA polymerase. J Mol Biol. 1972 Mar 28;65(2):259–272. doi: 10.1016/0022-2836(72)90281-1. [DOI] [PubMed] [Google Scholar]
  5. Hobby G. L., Lenert T. F. The antimycobacterial activity of rifampin. Am Rev Respir Dis. 1968 Apr;97(4):713–714. doi: 10.1164/arrd.1968.97.4.713. [DOI] [PubMed] [Google Scholar]
  6. Jones W. D., Jr, David H. L. Inhibition by fifampin of mycobacteriophage D29 replication in its drug-resistant host, Mycobacterium smergmatis ATCC 607. Am Rev Respir Dis. 1971 May;103(5):618–624. doi: 10.1164/arrd.1971.103.5.618. [DOI] [PubMed] [Google Scholar]
  7. Mindlin S. Z., Ilyina T. S., Voeykova T. A., Velkov V. V. Genetical analysis of rifampicin resistant mutants of E. coli K 12. Mol Gen Genet. 1972;115(2):115–121. doi: 10.1007/BF00277290. [DOI] [PubMed] [Google Scholar]
  8. Rabussay D., Zillig W. A rifampicin resistent rna-polymerase from E. coli altered in the beta-subunit. FEBS Lett. 1969 Oct 21;5(2):104–106. doi: 10.1016/0014-5793(69)80305-4. [DOI] [PubMed] [Google Scholar]
  9. Rynearson T. K., Shronts J. S., Wolinsky E. Rifampin: in vitro effect on atypical mycobacteria. Am Rev Respir Dis. 1971 Aug;104(2):272–274. doi: 10.1164/arrd.1971.104.2.272. [DOI] [PubMed] [Google Scholar]
  10. SELLERS M. I., BAXTER W. L., RUNNALS H. R. Growth characteristics of mycobacteriophages D28 and D29. Can J Microbiol. 1962 Jun;8:389–399. doi: 10.1139/m62-051. [DOI] [PubMed] [Google Scholar]
  11. Sippel A., Hartmann G. Mode of action of rafamycin on the RNA polymerase reaction. Biochim Biophys Acta. 1968 Mar 18;157(1):218–219. doi: 10.1016/0005-2787(68)90286-4. [DOI] [PubMed] [Google Scholar]
  12. Stinson M. W., Solotorovsky M. Interaction of Tween 80 detergent with mycobacteria in synthetic medium. I. Effect of Tween 80 on the growth and turbidimetric response of Mycobacterium avium cultures. Am Rev Respir Dis. 1971 Nov;104(5):717–727. doi: 10.1164/arrd.1971.104.5.717. [DOI] [PubMed] [Google Scholar]
  13. Tsukamura M. The pattern of resistance development to rifampicin in Mycobacterium tuberculosis. Tubercle. 1972 Jun;53(2):111–117. doi: 10.1016/0041-3879(72)90027-x. [DOI] [PubMed] [Google Scholar]
  14. Wehrli W., Knüsel F., Schmid K., Staehelin M. Interaction of rifamycin with bacterial RNA polymerase. Proc Natl Acad Sci U S A. 1968 Oct;61(2):667–673. doi: 10.1073/pnas.61.2.667. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Wehrli W., Knüsel F., Staehelin M. Action of rifamycin on RNA-polymerase from sensitive and resistant bacteria. Biochem Biophys Res Commun. 1968 Jul 26;32(2):284–288. doi: 10.1016/0006-291x(68)90382-3. [DOI] [PubMed] [Google Scholar]
  16. White R. J., Lancini G. C., Silvestri L. G. Mechanism of action of rifampin on Mycobacterium smegmatis. J Bacteriol. 1971 Nov;108(2):737–741. doi: 10.1128/jb.108.2.737-741.1971. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Woodley C. L., Kilburn J. O., David H. L., Silcox V. A. Susceptibility of mycobacteria to rifampin. Antimicrob Agents Chemother. 1972 Oct;2(4):245–249. doi: 10.1128/aac.2.4.245. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. YOUMANS A. S., YOUMANS G. P. Studies on the metabolism of Mycobacterium tuberculosis. IV. The effect of fatty acids on the growth of M. tuberculosis var. hominis. J Bacteriol. 1954 Jun;67(6):731–733. doi: 10.1128/jb.67.6.731-733.1954. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES